These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1995766)

  • 1. Prophylactic effect of self-administered pump-driven subcutaneous IgG infusion in patients with antibody deficiency: a triple-blind cross-over study comparing P-IgG levels of 3 g l-1 versus 6 g l-1.
    Remvig L; Andersen V; Hansen NE; Karle H
    J Intern Med; 1991 Jan; 229(1):73-7. PubMed ID: 1995766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
    Shapiro RS
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):51-5. PubMed ID: 23806460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies.
    Gustafson R; Gardulf A; Hansen S; Leibl H; Engl W; Lindén M; Müller A; Hammarström L
    Clin Exp Immunol; 2008 May; 152(2):274-9. PubMed ID: 18341618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.
    Gardulf A; Hammarström L; Smith CI
    Lancet; 1991 Jul; 338(8760):162-6. PubMed ID: 1712881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies.
    Shirani KZ; Vaughan GM; McManus AT; Amy BW; McManus WF; Pruitt BA; Mason AD
    Am J Med; 1984 Mar; 76(3A):175-80. PubMed ID: 6424447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases.
    Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L
    Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Build-up maintenance of IgG serum concentrations with intravenous immunoglobulin in patients with primary humoral immunodeficiency.
    Morell A; Schnoz M; Barandun S
    Vox Sang; 1982; 43(4):212-9. PubMed ID: 7135889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of immunoglobulins in pediatrics].
    Fischer A
    Arch Fr Pediatr; 1988 Dec; 45(10):779-81. PubMed ID: 3071284
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.
    Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH
    Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump.
    Wasserman RL; Cunningham-Rundles C; Anderson J; Lugar P; Palumbo M; Patel NC; Hofmann J; Glassman F; Rogers E; Praus M; Rojavin MA
    Immunotherapy; 2022 Nov; 14(16):1315-1328. PubMed ID: 36128795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin therapy in hypogammaglobulinemia. A review.
    Pirofsky B
    Am J Med; 1984 Mar; 76(3A):53-60. PubMed ID: 6424457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.
    Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ
    Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease.
    Roifman CM; Lederman HM; Lavi S; Stein LD; Levison H; Gelfand EW
    Am J Med; 1985 Aug; 79(2):171-4. PubMed ID: 4025374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subcutaneous immunoglobulin infusion in antibody deficiency substitution of a patient sensitized to intravenous immunoglobulins. Case report].
    Wiktor-Jedrzejczak W; Szwech P; Kruszewski AA; Raczka A; Zakrzewski A; Kłos M
    Pol Arch Med Wewn; 1997 Apr; 97(4):359-63. PubMed ID: 9411413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variable immune deficiency syndrome with antibody deficiency--long-term substitution with immunoglobulins].
    Vaith P; Maas D
    Immun Infekt; 1984 Apr; 12(2):123-8. PubMed ID: 6442916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of intravenous gamma globulin in multiple myeloma.
    Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C
    Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin replacement therapy by self-infusion at home.
    Chapel H; Brennan V; Delson E
    Clin Exp Immunol; 1988 Jul; 73(1):160-2. PubMed ID: 3168330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.
    Roifman CM; Levison H; Gelfand EW
    Lancet; 1987 May; 1(8541):1075-7. PubMed ID: 2883406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.